Investor's Business Daily on MSN
Obesity drugs covered in Medicare change. Questions remain for Lilly, Novo.
CMS flipped its stance late Tuesday, saying it will cover the cost of obesity drugs beginning July 1 through the end of 2027.
Hosted on MSN
Eli Lilly to buy Kelonia Therapeutics for up to $7B
Eli Lilly will purchase Kelonia Therapeutics in a deal worth up to $7 billion, gaining its lentiviral in vivo CAR-T platform and multiple myeloma therapy KLN-1010. The acquisition is part of Lilly’s ...
The US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 December 2027.
Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results